Chronic hypertension-induced cerebrovascular damage: identification of novel molecular targets at the immune-vascular interface Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:30
Tracking the transition from acute to memory phase by cell cycle analysis of antigen-specific CD8 T cells in vaccinated mice Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:29
Unveiling the role of mast cell-derived exosomes in the initiation of type 2 immune responses Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:26
Redirecting the natural history of HPV infection through Immune checkpoint inhibitors Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:20
Identificazione di nuovi biomarkers nel management delle infezioni associate al trattamento della sclerosi multipla con farmaci biologici Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:14
Possible correlation between immune and inflammatory profile and rheumatologic immune-related adverse events in oncologic patients treated with anti-PD-1/anti-PD-L1 checkpoints inhibitors. Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:14
Immunobiology of progressive platinum-resistant ovarian cancer: analysis of the immune-related protein profile in paired primary and recurrent tumor tissue samples. Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 10:01
Biobanks of primary cultures enriched with Lung Cancer Stem Cells (CSC) and adapted immune cells: targeting lipid metabolism and correlations patients risk factors Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 09:59
Manipulation of UPR in tumor cells and dendritic cells or macrophages exposed to tumor released factors to counteract tumor-induced immune dysfunction . Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 09:57
DEVELOPMENT AND APPLICATION OF FLOW CYTOMETRIC MULTI-IMMUNOASSAY ANALYSIS TO IDENTIFY IMMUNOCOMPROMISED INDIVIDUALS WITH LATENT TUBURCOLOSIS (LTBI) AT INCREASED RISK OF ACTIVE TB DEVELOPMENT Inviato da Anonimo (non verificato) il Mar, 19/04/2022 - 09:56